Table 2. Clinical and laboratorial characteristics.
| C (n = 27) | H T (n = 14) | G O (n = 21) | G D (n = 19) | HT+LT4 (n = 19) | |
|---|---|---|---|---|---|
| Gender (women/men) | 20/7 | 13/1 | 15/6 | 14/5 | 17/2 |
| Age (yr.)* | 51 | 46 | 58 | 54 | 52 |
| (39.2-66.2) | (30.2-64.5) | (44.7-66.5) | (48-58) | (46.5-55.5) | |
| BMI (kg/m2)** | 25.8 ± 3.8 | 26.6 ± 4.1 | 28.2 ± 4.49 | 27.1 ± 5.4 | 28.3 ± 5.3 |
| TSH (mU/L)** | 1.63 ± 0.72 | 3.00 ± 2.06 | 2.40 ± 2.09 | 1.45 ± 1.21 | 2.73 ± 2.39 |
| FreeT4 (ng/dL)** | 1.16 ± 0.20 | 1.23 ± 0.22 | 1.252 ± 0.279 | 1.278 ± 0.278 | 1.322 ± 0.237 |
| FreeT3 (µg/mL)* | 4.60 | 3.1 | 2.601 | 3.151 | 2.81 |
| (3.65-5.20) | (2.8-3.45) | (2.55-3.0) | (2.57-3.37) | (2.6-3.05) | |
| TgAb (UI/mL)* | 11.9 | 71.92 | 1.02 | 1.02 | 12.252 |
| (10.0-19.5) | (1.00-170.0) | (1.0-1.0) | (1.0-12.0) | (1.0-87.9) | |
| TPOAb (UI/mL) | 5.0 | 79.453 | 22.03 | 58.53 | 1463 |
| (5.0-9.70) | (47.32-209.7) | (7.0-62.75) | (16.5-405.5)3 | (54.5-325) | |
| TRAb (UI/L) | 0.65 | 1.08 | |||
| (0.30-4.86) | (0.41-3.92) |
*
Median and interquartile intervals; 25% and 75%;
**
Mean and standard deviation.
1
P < 0.0001 C vs. HT + LT4, C vs. GO, C vs. GD,
2
P < 0.0001 C vs. HT, C vs. HT + LT4, C vs. Go, C vs. GD,
3
P < 0.0001 HT vs. GO, HT vs. GD, HT + LT4 vs. GO, HT + LT4 vs. GD.